Prevalence of Diastasis m. Rectus Abdominis in Postpartum Women

NCT ID: NCT05051176

Last Updated: 2022-07-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

150 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-04-08

Study Completion Date

2022-05-23

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study will evaluate the prevalence of diastasis m. rectus abdominis after delivery.

Relationship of Diastasis Recti Abdominis with urine leakage, pelvic floor muscle function and morphometry in postpartum women.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Evaluation of the width of the linea alba within the evaluation of diastasis of the rectus abdominis by 2D USG relation to pelvic floor muscle function (strength and endurance of pelvic floor muscles) and pelvic floor muscle morphometry by 3D/4D USG .

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Diastasis of m. Rectus Abdominis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

2D usg and 3D/4D usg

IRD distance measured by a linear probe 2D usg. Pelvic floor muscle morphometry measured by 3D/4D usg

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Women from six weeks to up to 6 months after birth, age over 18 years old.

Exclusion Criteria

* Psychiatric illness, postpartum depression, non-cooperation. Neurological diseases conditions after a stroke, a history of brain injury, significant visual and hearing damage, confirmed by neurological examination. Serious internal, orthopedic and oncological diseases. Disagreement with inclusion in the study.
Minimum Eligible Age

18 Years

Maximum Eligible Age

40 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Pavol Jozef Safarik University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Rastislav Dudič, MD, PhD.

Faculty of Medicine

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Rastislav Dudič, PhD

Role: PRINCIPAL_INVESTIGATOR

Department of Gynecology and Obstetrics, Medical Faculty, PJ Safarik University, Kosice, Slovakia

Magdalena Hagovska, Prof,PhD

Role: STUDY_DIRECTOR

KFBLR, Medical Faculty, PJ Safarik University, Kosice, Slovakia

Jan Svihra, Prof,MD,PhD.

Role: STUDY_DIRECTOR

Department of Urology, Institution, Comenius University Bratislava, Slovakia

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

PJ Safarik University

Košice, , Slovakia

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Slovakia

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

4168/2021/ODDZ-11065

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.